Anakinra Therapy for Non-cancer Inflammatory Diseases
Interleukin-1 (IL-1) is the prototypical inflammatory cytokine: two distinct ligands (IL-1α and IL-1β) bind the IL-1 type 1 receptor (IL-1R1) and induce a myriad of secondary inflammatory mediators, including prostaglandins, cytokines, and chemokines. IL-1α is constitutively present in endothelial a...
Main Authors: | Giulio Cavalli, Charles A. Dinarello |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2018-11-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fphar.2018.01157/full |
Similar Items
-
Corrigendum: Anakinra Therapy for Non-cancer Inflammatory Diseases
by: Giulio Cavalli, et al.
Published: (2019-03-01) -
Accumulation of Inflammatory Mediators in the Normal Pericardial Fluid
by: Mohammad M. El-Diasty, et al.
Published: (2023-12-01) -
Evaluation of pro-inflammatory and anti-inflammatory cytokines in type 1 diabetes mellitus
by: Weaam Gouda, et al.
Published: (2018-10-01) -
Application of anakinra in inflammatory dermatoses
by: Xiaomei YOU, et al.
Published: (2024-01-01) -
IL-38 Gene Deletion Worsens Murine Colitis
by: Dennis M. de Graaf, et al.
Published: (2022-05-01)